The Journal of Allergy and Clinical Immunology (2019) doi.org/10.1016/j.jaci.2019.09.015
Limited evidence suggests increased fracture risk in people with atopic eczema. Any link could have substantial effect; atopic eczema is common, and fractures have associated morbidity and mortality.
We sought to examine whether atopic eczema is associated with fracture and whether fracture risk varies with eczema severity.
We performed a matched cohort study set in primary care (Clinical Practice Research Datalink GOLD 1998-2016) and linked hospital admissions data (Hospital Episode Statistics), including adults (≥18 years old) with atopic eczema matched (by age, sex, general practice, and cohort entry date) with up to 5 individuals without eczema. We estimated hazard ratios (HRs) from stratified Cox regression comparing risk of major osteoporotic (hip, pelvis, spine, wrist, and proximal humerus) fractures individually and any fracture in those with and without atopic eczema.
We identified 526,808 people with atopic eczema and 2,569,030 people without atopic eczema. Those with eczema had increased risk of hip (HR, 1.10; 99% CI, 1.06-1.14), pelvic (HR, 1.10; 99% CI, 1.02-1.19), spinal (HR, 1.18; 99% CI, 1.10-1.27), and wrist (HR, 1.07; 99% CI, 1.03,-1.11) fractures. We found no evidence of increased proximal humeral (HR, 1.06; 99% CI, 0.97-1.15) fracture risk. Fracture risk increased with increasing eczema severity, with the strongest associations in people with severe eczema (compared with those without) for spinal (HR, 2.09; 99% CI, 1.66-2.65), pelvic (HR, 1.66; 99% CI, 1.26-2.20), and hip (HR, 1.50; 99% CI, 1.30-1.74) fractures. Associations persisted after oral glucocorticoid adjustment.
People with atopic eczema have increased fracture risk, particularly major osteoporotic fractures.
Investigating the links between father chemotherapy and gene mutation rates in children
24 November 2022
Research into families with high gene mutation rates, that could lead to rare diseases, has found a link to the biological father receiving certain chemotherapy treatments.
The rise of tech in health data research: A new and evolving way of treating mental illness in the UK
7 October 2022
Having lived with diabetes since the age of one, 34-year-old Londoner Manveer Sahota has always had a good understanding of his condition, its impact on his daily life and the long-term health...
Call for UK data custodians to map health data for public benefit is open
3 October 2022
Health Data Research UK (HDR UK) and the UK Health Data Research Alliance in collaboration with the European Health Data & Evidence Network (EHDEN) have opened their call for UK data custodians to...